Free shipping on all orders over $ 500

Subasumstat

Cat. No. M9634

All AbMole products are for research use only, cannot be used for human consumption.

Subasumstat Structure
Synonym:

TAK-981

Size Price Availability Quantity
1mg USD 76  USD76 In stock
5mg USD 179  USD179 In stock
10mg USD 279  USD279 In stock
25mg USD 498  USD498 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Subasumstat (TAK-981) is a potent and selective SUMOylation enzymatic cascade inhibitor with potential immune-activating and antineoplastic activities. Subasumstat (TAK-981) targets and covalently binds to the small ubiquitin-like modifier (SUMO; small ubiquitin-related modifier) protein, which prevents the transfer of SUMO from the SUMO-activating enzyme (SAE) to SUMO-conjugating enzyme UBC9. Subasumstat (TAK-981) is able to increase the production of type 1 IFN, thereby increasing type 1 IFN-mediated signaling, activating innate effector cells and enhancing the antitumor innate immune responses.

Chemical Information
Molecular Weight 578.10
Formula C25H28ClN5O5S2
CAS Number 1858276-04-6
Solubility (25°C) DMSO ≥ 18 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Sumit Kumar, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

[2] Li Du, et al. SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma

[3] Antti Kukkula, et al. Therapeutic Potential of Targeting the SUMO Pathway in Cancer

[4] Li Du, et al. Targeting SUMOylation in cancer

[5] Steven P Langston, et al. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer

Related E1/E2/E3 Enzyme Products
NSC697923

NSC697923 is a cell-permeable and selective inhibitor of the Ub-conjugating enzyme (E2) complex Ubc13-Uev1A.

PYR-41

PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2.

CC0651

CC0651 is an allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme and inhibited the ubiquitination of p27Kip1 with IC50 value of 1.72 μM.

Iberdomide

Iberdomide (CC-220) is an orally effective cereblon (CRBN) E3 ligase modulator (CELMoD) with an IC50 for cereblon binding affinity of approximately 150 nM. Iberdomide (CC-220) binds CRBN with higher affinity than lenalidomide and pomalidomide and has enhanced degradation of IKZF1 and IKZF3 with enhanced degradation.

Ginkgolic Acid

Ginkgolic Acid is a inhibits SUMOylation by binding E1.

  Catalog
Abmole Inhibitor Catalog




Keywords: Subasumstat, TAK-981 supplier, E1/E2/E3 Enzyme, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.